Novanta NOVT Medical Solutions — Cost of Goods Sold

Other segment segments

Similar metrics at other companies

REZIProducts and Solutions — Cost of goods sold

$411M+8.2%

BSXMedSurg — Cost of products sold

$478M+9.9%

WMHealthcare Solutions — Cost of Goods Sold

$500M+4.2%

MDTMedical Surgical — Cost of products sold, excluding amortization of intangible assets

$964M+10.8%

NDSNMedical and Fluid Solutions — Adjusted cost of sales

-$108.17M-6.7%

SOLVMedSurg — Cost of Sales

$622M+13.5%

Questions, answered.

What is Novanta's medical solutions — cost of goods sold?

Novanta (NOVT) reported medical solutions — cost of goods sold of $71.73M in Q1 2026.

How has Novanta's medical solutions — cost of goods sold changed year-over-year?

Novanta's medical solutions — cost of goods sold increased by 15.6% year-over-year, from $62.04M to $71.73M.

What is the long-term trend for Novanta's medical solutions — cost of goods sold?

Over 3 years (2022 to 2025), Novanta's medical solutions — cost of goods sold has grown at a 14.0% compound annual growth rate (CAGR), from $181.91M to $269.36M.

What does medical solutions — cost of goods sold mean?

The direct costs attributable to the production of goods and the delivery of services within the Medical Solutions segment. This includes raw materials, direct labor, and manufacturing overhead required to generate the segment's revenue.